Lexpos News

/Lexpos News

Medicine Supply Notification: Ofloxacin 200mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Ofloxacin 200mg tablets. MSN/2022/091 Tier 2 – medium impact Date of issue 27th October 2022 Ofloxacin 200mg tablets are out of stock from mid-November until mid-December 2022. Alternative fluoroquinolone antibiotics are available and can support a full uplift in demand. If alternative [...]

The post Medicine Supply Notification: Ofloxacin 200mg tablets appeared first on PSNC Website.

By |October 27th, 2022|Lexpos News|Comments Off on Medicine Supply Notification: Ofloxacin 200mg tablets

Medicine Supply Notification: Fentanyl (Effentora® ) 200 microgram and 400 microgram buccal tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Fentanyl (Effentora® ) 200 microgram and 400 microgram buccal tablets. MSN/2022/090 Tier 2 – medium impact Date of issue 27th October 2022 Effentora® 200 microgram buccal tablets are out of stock until late November 2022 and Effentora® 400 microgram buccal tablets are [...]

The post Medicine Supply Notification: Fentanyl (Effentora® ) 200 microgram and 400 microgram buccal tablets appeared first on PSNC Website.

By |October 27th, 2022|Lexpos News|Comments Off on Medicine Supply Notification: Fentanyl (Effentora® ) 200 microgram and 400 microgram buccal tablets

Reminder: Have you signed up for priority access to utilities?

As part of business continuity arrangements, community pharmacy contractors are reminded that they can sign up for the Priority Services Register to boost their business continuity arrangements further. The Priority Services Register is run by the UK’s utility companies. Inclusion on this register should mean your pharmacy has priority access to electricity, water and gas supplies. [...]

The post Reminder: Have you signed up for priority access to utilities? appeared first on PSNC Website.

By |October 27th, 2022|Lexpos News|Comments Off on Reminder: Have you signed up for priority access to utilities?

Class 3 Medicines Recall: Mebeverine hydrochloride 135mg Film-coated tablets

Drug alert number: EL (22) A/46 Date issued: 27th October 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Mebeverine hydrochloride 135mg Film-coated tablets (Medreich PLC) – PL 21880/0247 Batch Number Expiry Date Pack Size First Distributed B11539 11/2024 100 tablets 25 August 2022 Active Pharmaceutical Ingredient: [...]

The post Class 3 Medicines Recall: Mebeverine hydrochloride 135mg Film-coated tablets appeared first on PSNC Website.

By |October 27th, 2022|Lexpos News|Comments Off on Class 3 Medicines Recall: Mebeverine hydrochloride 135mg Film-coated tablets

Drug Tariff Watch – November 2022

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 November 2022. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. § Selected [...]

The post Drug Tariff Watch – November 2022 appeared first on PSNC Website.

By |October 27th, 2022|Lexpos News|Comments Off on Drug Tariff Watch – November 2022